BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12598432)

  • 1. Utilities associated with diabetic retinopathy: results from a Canadian sample.
    Sharma S; Oliver-Fernandez A; Bakal J; Hollands H; Brown GC; Brown MM
    Br J Ophthalmol; 2003 Mar; 87(3):259-61. PubMed ID: 12598432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility values and diabetic retinopathy.
    Brown MM; Brown GC; Sharma S; Shah G
    Am J Ophthalmol; 1999 Sep; 128(3):324-30. PubMed ID: 10511027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparities between Ophthalmologists and Patients in Estimating Quality of Life Associated with Diabetic Retinopathy.
    Zhu X; Sun Q; Zou H; Xu X; Zhang X
    PLoS One; 2015; 10(12):e0143678. PubMed ID: 26630653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing disutility associated with diabetic retinopathy, diabetic macular oedema and associated visual impairment using the Vision and Quality of Life Index.
    Fenwick EK; Xie J; Pesudovs K; Ratcliffe J; Chiang PP; Finger RP; Lamoureux EL
    Clin Exp Optom; 2012 May; 95(3):362-70. PubMed ID: 22537275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration.
    Brown MM; Brown GC; Sharma S; Landy J; Bakal J
    Arch Ophthalmol; 2002 Apr; 120(4):481-4. PubMed ID: 11934322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of anchor point on utilities for 5 common ophthalmic diseases.
    Lee BS; Kymes SM; Nease RF; Sumner W; Siegfried CJ; Gordon MO
    Ophthalmology; 2008 May; 115(5):898-903.e4. PubMed ID: 17826833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TTO utility scores measure quality of life in patients with visual morbidity due to diabetic retinopathy or ARMD.
    Shah VA; Gupta SK; Shah KV; Vinjamaram S; Chalam KV
    Ophthalmic Epidemiol; 2004 Feb; 11(1):43-51. PubMed ID: 14977496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients.
    Sharma S; Brown GC; Brown MM; Hollands H; Robins R; Shah GK
    Br J Ophthalmol; 2002 May; 86(5):493-6. PubMed ID: 11973240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health utility values associated with diabetic retinopathy.
    Lloyd A; Nafees B; Gavriel S; Rousculp MD; Boye KS; Ahmad A
    Diabet Med; 2008 May; 25(5):618-24. PubMed ID: 18346157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability of the time trade-off technique of utility assessment in patients with retinal disease.
    Hollands H; Lam M; Pater J; Albiani D; Brown GC; Brown M; Cruess AF; Sharma S
    Can J Ophthalmol; 2001 Jun; 36(4):202-9. PubMed ID: 11428529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient preferences for diabetic retinopathy health States.
    Szabo SM; Beusterien KM; Pleil AM; Wirostko B; Potter MJ; Tildesley H; Gonder J; Barsdorf A; Levy AR
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3387-94. PubMed ID: 20053977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converting visual acuity to utilities.
    Sharma S; Brown GC; Brown MM; Shah GK; Snow K; Brown H; Hollands H
    Can J Ophthalmol; 2000 Aug; 35(5):267-72. PubMed ID: 10959467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER.
    Broman AT; Munoz B; Rodriguez J; Sanchez R; Quigley HA; Klein R; Snyder R; West SK
    Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3393-8. PubMed ID: 12407148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a novel diabetic retinopathy utility index using discrete choice experiments.
    Fenwick EK; Bansback N; Gan ATL; Ratcliffe J; Burgess L; Wong TY; Lamoureux EL
    Br J Ophthalmol; 2020 Feb; 104(2):188-193. PubMed ID: 31097442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The longitudinal link between visual acuity and health-related quality of life in patients with diabetic retinopathy.
    Matza LS; Rousculp MD; Malley K; Boye KS; Oglesby A
    Health Qual Life Outcomes; 2008 Nov; 6():95. PubMed ID: 18992161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of diabetic retinopathy on participation in daily living.
    Lamoureux EL; Hassell JB; Keeffe JE
    Arch Ophthalmol; 2004 Jan; 122(1):84-8. PubMed ID: 14718300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inter-relationship between visual symptoms, activity limitation and psychological functioning in patients with diabetic retinopathy.
    Fenwick EK; Cheng GH; Man REK; Khadka J; Rees G; Wong TY; Pesudovs K; Lamoureux EL
    Br J Ophthalmol; 2018 Jul; 102(7):948-953. PubMed ID: 28928266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vision and quality-of-life.
    Brown GC
    Trans Am Ophthalmol Soc; 1999; 97():473-511. PubMed ID: 10703139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of visual impairment on health-related quality of life in rural Africa.
    Briesen S; Roberts H; Finger RP
    Ophthalmic Epidemiol; 2014 Oct; 21(5):297-306. PubMed ID: 25133670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.
    Kristinsson JK
    Acta Ophthalmol Scand Suppl; 1997; (223):1-76. PubMed ID: 9559048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.